Purpose
|
Tegaserod is a 5-HT4 agonist manufactured by Novartis and used for the management of irritable bowel syndrome and constipation. Its use was the only drug approved by the United States Food and Drug Administration to help relieve the abdominal discomfort, bloating and constipation associated with irritable bowel syndrome. On March 30, 2007, the U.S. Food and Drug Administration requested that Novartis withdraw Zelnorm from shelves. The FDA alleges a relationship between prescriptions of the drug and increased risks of heart attack or stroke.
|
Characteristics
|
Tradename: ZELNORM Source of Compound: synthetic, HTF-919 Target: 5-HT Receptor antagonist,Serotonin uptake inhibitor Receptor: 5-HT receptor , Sodium-dependent serotonin transporter Status: USAN, INN, BAN
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
98?%
|
Formula
|
C20H27N5O5
|
Solubility
|
DMSO:35mg/mL
|